Top

Published in:

Open Access 01-12-2021 | Multiple Sclerosis | Research

Validity and reliability of the Georgian-language brief international cognitive assessment for multiple sclerosis (BICAMS)

Authors: Nazibrola Botchorishvili, Nino Shiukashvili, Nina Mikeladze, Ann Dzagnidze, Nino Mikava, Maia Tighashvili, Marina Janelidze

Published in: BMC Neurology | Issue 1/2021

Abstract

Background

Cognitive impairment is one of the common features of multiple sclerosis (MS). Despite high prevalence, cognitive decline is often overlooked by neurologists. The Brief International Cognitive Assessment for MS (BICAMS) was therefore introduced by the international expert committee as a brief and effective tool for the assessment and monitoring of cognitive functions in patients with MS. The validity and reliability of BICAMS have been demonstrated in many countries. Our aim was to validate the BICAMS in Georgian patients with MS.

Methods

A total of 68 patients with MS and 68 matched controls were assessed by the Georgian-language BICAMS. All healthy controls and seven patients were re-evaluated with identical tests to assess retest reliability.

Results

In comparison to healthy controls, patients with MS performed significantly worse on all tests in the assessment battery. Test–retest reliability measures were good for all tests. The prevalence of cognitive impairment in patients with MS was 43%.

Conclusion

The Georgian-language BICAMS is a reliable and valid battery for the assessment of cognitive function in patients with MS.

Peterson LK, Fujinami RS. Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis. J Neuroimmunol. 2007;184:37–44. https://doi.org/10.1016/j.jneuroim.2006.11.015.CrossRefPubMed

Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, Vukusic S, et al. Multiple sclerosis. Nat Rev Dis. 2018;4:49. https://doi.org/10.1038/s41572-018-0041-4.CrossRef

Amato MP, Zipoli V, Portaccio E. Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. J Neurol Sci. 2006;245:41–6. https://doi.org/10.1016/j.jns.2005.08.019.CrossRefPubMed

Benedict RH, Zivadinov R. Risk factors for and management of cognitive dysfunction in multiple sclerosis. Nat Reviews Neurol. 2011;7:332. https://doi.org/10.1038/nrneurol.2011.61.CrossRef

Denney DR, Sworowski LA, Lynch SG. Cognitive impairment in three subtypes of multiple sclerosis. Arch Clin Neuropsychol. 2005;20:967–81. https://doi.org/10.1016/j.acn.2005.04.012.CrossRefPubMed

Brochet B, Ruet A. Cognitive impairment in multiple sclerosis with regards to disease duration and clinical phenotypes. Front Neurol. 2019;10:261. https://doi.org/10.3389/fneur.2019.00261.CrossRefPubMedPubMedCentral

Ruano L, Portaccio E, Goretti B, Niccolai C, Severo M, Patti F, Cilia S, Gallo P, Grossi P, Ghezzi A, Roscio M, Mattioli F, Stampatori C, Trojano M, Viterbo RG, Amato MP. Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes. Mult Scler. 2017;23(9):1258–67. https://doi.org/10.1177/1352458516674367 (Epub 2016 Oct 13 PMID: 27738090).CrossRefPubMed

Planche V, Gibelin M, Cregut D, Pereira B, Clavelou P. Cognitive impairment in a population-based study of patients with multiple sclerosis: differences between late relapsing-remitting, secondary progressive and primary progressive multiple sclerosis. Eur J Neurol. 2016;23(2):282–9. https://doi.org/10.1111/ene.12715 (Epub 2015 Apr 22 PMID: 25903918).CrossRefPubMed

Clemens L, Langdon D. How does cognition relate to employment in multiple sclerosis? A systematic review. Mult Scler Relat Disord. 2018;26:183–91. https://doi.org/10.1016/j.msard.2018.09.018.CrossRefPubMed

10.

Langdon DW, Amato MP, Boringa J, Brochet B, Foley F, Fredrikson S, et al. Recommendations for a brief international cognitive assessment for multiple sclerosis (BICAMS). Mult Scler. 2012;18:891–8. https://doi.org/10.1177/1352458511431076.CrossRefPubMedPubMedCentral

11.

Benedict RH, Amato MP, Boringa J, Brochet B, Foley F, Fredrikson S, et al. Brief International Cognitive Assessment for MS (BICAMS): international standards for validation. BMC neurol. 2012;12:55.CrossRef

12.

Smith A. The symbol-digit modalities test: a neuropsychologic test of learning and other cerebral disorders. In: Helmuth J, editor. Learning disorders. Seattle: Special Child Publications; 1968. p. 83–91.

13.

Smith A. Symbol digits modalities test. Los Angeles: Western Psychological Services; 1982.

14.

Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test-Second Edition (CVLT-II). San Antonio: The Psychological Corporation; 2000.

15.

Benedict RH. Brief Visuospatial Memory Test-Revised (BVMT-R). Odessa: Psychological Assessment Resources; 1997.

16.

Corfield F, Langdon D. A systematic review and meta-analysis of the Brief Cognitive Assessment for Multiple Sclerosis (BICAMS). Neurol Ther. 2018;7:287–306. https://doi.org/10.6084/m9.figshare.6490256.CrossRefPubMedPubMedCentral

17.

International Test Commission. The ITC Guidelines for Translating and Adapting Tests. 2nd ed. 2017.

18.

Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71. https://doi.org/10.1001/archpsyc.1961.01710120031004.CrossRefPubMed

19.

Johnen A, Bürkner PC, Landmeyer NC, Ambrosius B, Calabrese P, Motte J, et al. Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS). J Neurol. 2019;266:386–97. https://doi.org/10.1007/s00415-018-9142-y.CrossRefPubMed

20.

Patti F, Leone C, D’Amico E. Treatment options of cognitive impairment in multiple sclerosis. Neurol Sci. 2010;31(Suppl 2):S265–9. https://doi.org/10.1007/s10072-010-0438-7 (PMID: 20953811).CrossRefPubMed

21.

Landmeyer NC, Bürkner PC, Wiendl H, Ruck T, Hartung HP, Holling H, Meuth SG, Johnen A. Disease-modifying treatments and cognition in relapsing-remitting multiple sclerosis: A meta-analysis. Neurology. 2020;94(22):e2373–83. https://doi.org/10.1212/WNL.0000000000009522 (Epub 2020 May 19 PMID: 32430312).CrossRefPubMed

22.

DeLuca J, Chiaravalloti ND, Sandroff BM. Treatment and management of cognitive dysfunction in patients with multiple sclerosis. Nat Rev Neurol. 2020;16(6):319–32. https://doi.org/10.1038/s41582-020-0355-1 (Epub 2020 May 5 PMID: 32372033).CrossRefPubMed

23.

D’Amico E, Leone C, Hayrettin T, Patti F. Can we define a rehabilitation strategy for cognitive impairment in progressive multiple sclerosis? A critical appraisal Mult Scler. 2016;22(5):581–9. https://doi.org/10.1177/1352458516632066 (Epub 2016 Feb 26 PMID: 26920381).CrossRefPubMed

24.

Nygaard GO, de Rodez Benavent SA, Harbo HF, Laeng B, Sowa P, Damangir S, Bernhard Nilsen K, Etholm L, Tønnesen S, Kerty E, Drolsum L, Inge Landrø N, Celius EG. Eye and hand motor interactions with the symbol digit modalities test in early multiple sclerosis. Mult Scler Relat Disord. 2015;4(6):585–9. https://doi.org/10.1016/j.msard.2015.08.003 (Epub 2015 Aug 15 PMID: 26590666).CrossRefPubMed

25.

O’Connell K, Langdon D, Tubridy N, Hutchinson M, McGuigan C. A Preliminary Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) Tool in an Irish Population With Multiple Sclerosis (MS). Mult Scler Relat Disord. 2015;4:521–5. https://doi.org/10.1016/j.msard.2015.07.012 (Epub 2015 Aug 7).CrossRefPubMed

26.

Sandi D, Rudisch T, Füvesi J, Fricska-Nagy Z, Huszka H, Biernacki T, et al. The Hungarian validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery and the correlation of cognitive impairment with fatigue and quality of life. Mult Scler Relat Disord. 2015;4:499–504. https://doi.org/10.1016/j.msard.2015.07.006.CrossRefPubMed

27.

Ozakbas S, Yigit P, Cinar BP, Limoncu H, Kahraman T, Kösehasanoğulları G. The Turkish validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) battery. BMC Neurol. 2017;17:208. https://doi.org/10.1186/s12883-017-0993-0.CrossRefPubMedPubMedCentral

28.

Spedo CT, Frndak SE, Marques VD, Foss MP, Pereira DA, Carvalho LDF, et al. Cross-cultural adaptation, reliability, and validity of the BICAMS in Brazil. Clin Neuropsychol. 2015;29:836–46. https://doi.org/10.1080/13854046.2015.1093173.CrossRefPubMed

29.

Sheridan LK, Fitzgerald HE, Adams KM, Nigg JT, Martel MM, Puttler LI, et al. Normative Symbol Digit Modalities Test performance in a community-based sample. Arch Clin Neuropsychol. 2006;21:23–8. https://doi.org/10.1016/j.acn.2005.07.003.CrossRefPubMed

Title: Validity and reliability of the Georgian-language brief international cognitive assessment for multiple sclerosis (BICAMS)
Authors: Nazibrola Botchorishvili
Nino Shiukashvili
Nina Mikeladze
Ann Dzagnidze
Nino Mikava
Maia Tighashvili
Marina Janelidze
Publication date: 01-12-2021
Publisher: BioMed Central
Keyword: Multiple Sclerosis
Published in: BMC Neurology / Issue 1/2021
Electronic ISSN: 1471-2377
DOI: https://doi.org/10.1186/s12883-021-02249-x

2024 ASCO Annual Meeting

Springer Medicine

Validity and reliability of the Georgian-language brief international cognitive assessment for multiple sclerosis (BICAMS)

Abstract

Background

Methods

Results

Conclusion

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2021

Inner diameters of the normal carotid arteries measured using three-dimensional digital subtraction catheter angiography: a retrospective analysis

Association of neutrophil-to-lymphocyte ratio (NLR) with the prognosis of first attack neuromyelitis optica spectrum disorder (NMOSD): a retrospective cohort study

Thermographic follow-up of postherpetic neuralgia (PHN) subsequent to Ramsay Hunt syndrome with multicranial nerve (V, VII, VIII and IX) involvement: a case report

Safety and efficacy of interleukin-6-receptor inhibitors in the treatment of neuromyelitis optica spectrum disorders: a meta-analysis

Steroid responsive cavernous sinus syndrome due to Rosai-Dorfman disease: beyond Tolosa-Hunt syndrome – a case report

Optimizing telemedical care in neurological outpatients by characterizing the patients’ needs in the physician–patient relationship—content analysis of guideline-based interviews